via John Innes Centre
Compounds tested for their potential as antibiotics have demonstrated promising activity against one of the deadliest infectious diseases – tuberculosis (TB).
Researchers from the John Innes Centre evaluated two compounds with antibacterial properties, which had been produced by the company Redx Pharma as antibiotic candidates, particularly against TB.
TB, which is caused by the bacterium Mycobacterium tuberculosis, is often thought of as a disease of the past. But in recent years it has been increasing due, in part, to rising resistance to treatments and decreasing efficacy of vaccines.
One strategy in the search for new treatments is to find compounds that exploit well-known existing targets for drugs such as the bacterial enzyme DNA gyrase. This member of the DNA topoisomerase family of enzymes is required for bacterial DNA functionality, so compounds that inhibit its activity are much sought after as antibiotic candidates.
Using X-ray crystallography, the team elucidated the molecular details of the action of the compounds against their target.
Surprisingly, a very common mutation in DNA gyrase that causes bacteria to be resistant to a related group of antibiotics, the aminocoumarins, did not lead to resistance to the compounds under scrutiny here.
“We hope that companies and academic groups working to develop new antibiotics will find this study useful. It opens the way for further synthesis and investigation of compounds that interact with this target,” says Professor Tony Maxwell one of the authors of the study which appears in the Journal of Antimicrobial Chemotherapy.
To date, efforts to develop new treatments for TB have been unsuccessful, with current treatments having been used for over 50 years.
World Health Organisation (WHO) figures reveal that each day over 4,000 people die from TB and 300,000 people fall ill from the disease. Nearly 500,000 people fell ill with drug-resistant TB in 2018.
Professor Maxwell says: “Antimicrobial resistance (AMR) is now well-recognised as one of the biggest problems facing us in the in the 21st Century. If we don’t find solutions to it soon, we could be looking at epidemics of bacterial disease going forward.”
“People know about the bubonic plague and other such terrible pestilence through studying history but it’s not overstating the case that bacterial diseases of this sort could reemerge if we do not have effective antibiotics. We must find a way of bringing together expertise from the academic and business sector towards decisive action.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Starving Tuberculosis of sugars may be a new way to fight iton April 15, 2021 at 12:36 am
Tuberculosis is one of the leading causes of death from a single infectious agent in the world, but the nutrients that the pathogen uses to survive ...
- Group urges support for fight against tuberculosison April 14, 2021 at 10:17 pm
The National Tuberculosis and Leprosy Control Programme has urged the media to assist in enlightening the public on the causes, prevention and treatment of tuberculosis . The Director a Uko, made the ...
- Nigeria: Tuberculosis Kills 18 People Per Hour in Nigeria - Reporton April 14, 2021 at 9:56 pm
No fewer than 18 persons die of tuberculosis per hour in Nigeria according to a report by the World Health Organization, WHO.
- Ondo govt to embark on tuberculosis awareness campaignon April 14, 2021 at 8:52 pm
Ondo government says it will soon embark on sensitisation of community and religious leaders on the dangers of tuberculosis.
- Tuberculosis kills 18 persons per hour in Nigeria ― Reporton April 14, 2021 at 12:43 pm
No fewer than 18 persons die of tuberculosis per hour in Nigeria according to a report by the World Health Organization, WHO. The Director, National Tuberculosis & Leprosy Control Programme, Mrs.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Global shortage of innovative antibiotics fuels emergence and spread of drug-resistanceon April 15, 2021 at 1:54 am
The world is still failing to develop desperately needed antibacterial treatments, despite growing awareness of the urgent threat of ...
- Novel antibiotic deceives bacteria through mimicryon April 15, 2021 at 12:21 am
The antibiotic darobactin mimics a ß-strand to inhibit outer membrane insertase. Nature (2021). Doi 10.1038/s41586-021-03455-w: ...
- Nanotech Layer Placed On Wound Dressings Kills Antibiotic-Resistant Bacteria With 99% Effectivenesson April 14, 2021 at 8:34 am
Despite stark warnings from microbiologists for the last decade, the world is still far too reliant on antibiotics. From prescribing them for diseases that ...
- The Antibiotic Resistance Market To Be In Sync With Technology, Reach US$ 12.6 Bnon April 13, 2021 at 1:45 pm
The Antibiotic Resistance Market report by Persistence Market Research goes by the changing trend of consumerism all across the healthcare vertical. “Going cashless” is amongst the “new” normals.
- Consortium to address antimicrobial resistanceon April 12, 2021 at 5:00 pm
TRANSFORM will focus on minimizing the risks of antimicrobial resistance (AMR) and zoonoses spread from animals to humans such as foodborne pathogens, anthrax and avian and swine influenza. The ...